Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

COVID-19: Additional Guidance on Paycheck Protection Program Second Draw Loans

Alerts

Department of Public Service Staff and NYSERDA Release Initial Report on the New York Power Grid Study Addressing Key System Needs

Alerts

Not So Fast! US Supreme Court Puts the Brakes on Lower Courts' Bankruptcy Rulings for City of Chicago's Vehicle Takings

Alerts

NYS Department of Labor Releases New Guidance Significantly Expanding COVID-19 Sick Leave Benefits

Alerts

Is This the Year for Adult-Use Cannabis in NYS?

Alerts

Brace for Changes to Patent Assignor Estoppel—Impact on Contractual Provisions

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out